Recently, Jin et al. reported that using in vitro and in vivo a CpG@CNTs complex on colorectal cancer cells CpG uptake was significantly enhanced, NF-κB signal was activated, and local xenograft tumour growth and liver metastasis were suppressed. The gene discussed is NFKB1; the disease is neoplasm.